| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0026 | 1 |